Outset Medical, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2020-08-17

Reporting Person: Trigg Leslie (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-17	Common Stock	M	68355	$1.11	Acquired	161580	Direct
2020-09-17	Common Stock	C	7571	—	Acquired	8770	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-17	Stock Option (Right to Buy)	$1.11	M	68355	Disposed	2025-03-13	Common Stock (68355)	Direct
2020-09-17	Series C Redeemable Convertible Preferred Stock	$	C	38588	Disposed		Common Stock (4885)	Indirect
2020-09-17	Series D Redeemable Convertible Preferred Stock	$	C	16078	Disposed		Common Stock (2686)	Indirect

Footnotes

F1: These shares of common stock of the Issuer ("Shares") are held directly by The Trigg Family Trust U/A DTD 01/01/2002, for which the reporting person and her spouse serve as trustees.

F2: This option vested in 48 equal monthly installments beginning on December 17, 2014.

F3: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020.

F4: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date.

F5: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date.